Yahoo
NYSE - Nasdaq Real Time Price USD

STERIS plc (STE)

227.66 -4.49 (-1.93%)
As of 1:29:37 PM EDT. Market Open.
Trade STERIS on Coinbase
Dividend
STE announced a cash dividend of $0.69 with an ex-date of Nov. 17, 2026

Key Executives

Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Daniel A. Carestio
President, CEO & Director 2.84M -- 1973
Ms. Karen L. Burton
Senior VP, CFO & Chief Accounting Officer 1.04M 1.01M 1968
Mr. John Adam Zangerle
Senior VP, General Counsel & Secretary 1.13M 2.93M 1967
Ms. Mary Clare Fraser
SVP & Chief Human Resources Officer 854.78k -- 1970
Mr. Cary L. Majors
Senior VP & President of Healthcare 1.03M 1.32M 1975
Ms. Julie Winter
Vice President of Investor Relations & Corporate Communications -- -- --
Ms. Lindsey McGowan
VP, Chief Compliance & Quality Officer -- -- --
Ms. Julia K. Madsen
Senior VP & GM of Life Sciences -- -- 1965
Mr. Andrew Xilas
Senior VP & GM of Dental 1.44M -- 1965
Mr. Kenneth E. Kohler
Senior VP & GM of AST -- -- 1963

STERIS plc

5960 Heisley Road
Mentor, OH 44060
United States
440 354 2600 https://www.steris.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
17,937

Description

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Corporate Governance

STERIS plc’s ISS Governance QualityScore as of October 1, 2026 is 8. The pillar scores are Audit: 9; Board: 4; Shareholder Rights: 8; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 4, 2026 at 8:00 PM UTC

STERIS plc Earnings Date

November 17, 2026 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

October 13, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 25, 2026 at 12:00 AM UTC

Dividend Date

August 7, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 16, 2026 at 12:00 AM UTC

11-K: Annual report of employee stock purchase

June 11, 2026 at 12:00 AM UTC

DEF 14A: Proxy Statements

June 1, 2026 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 29, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

May 11, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: